Zollinger-Ellison syndrome other imaging findings: Difference between revisions
| Line 9: | Line 9: | ||
*[[Somatostatin receptor]] scintigraphy (SRS) (octreotide scan)<ref name="pmid9274481">{{cite journal| author=Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Ruszniewski P, Le Guludec D et al.| title=Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). | journal=Gut | year= 1997 | volume= 41 | issue= 1 | pages= 107-14 | pmid=9274481 | doi= | pmc=PMC1027237 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9274481 }} </ref> | *[[Somatostatin receptor]] scintigraphy (SRS) (octreotide scan)<ref name="pmid9274481">{{cite journal| author=Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Ruszniewski P, Le Guludec D et al.| title=Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). | journal=Gut | year= 1997 | volume= 41 | issue= 1 | pages= 107-14 | pmid=9274481 | doi= | pmc=PMC1027237 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9274481 }} </ref> | ||
==Gallery== | ==Gallery== | ||
<gallery widths=200px> | <gallery widths=200px class="center"> | ||
SRS1.jpg| A | SRS1.jpg| A | ||
SRS2.jpg| B | SRS2.jpg| B | ||
Revision as of 15:40, 2 October 2015
|
Zollinger-Ellison syndrome Microchapters |
|
Differentiating Zollinger-Ellison syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Zollinger-Ellison syndrome other imaging findings On the Web |
|
American Roentgen Ray Society Images of Zollinger-Ellison syndrome other imaging findings |
|
Zollinger-Ellison syndrome other imaging findings in the news |
|
Risk calculators and risk factors for Zollinger-Ellison syndrome other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Endoscopic ultrasound and Somatostatin receptor scintigraphy (SRS) (octreotide scan) may be helpful in the diagnosis of Zollinger-Ellison syndrome caused by gastrinoma.[1]
Other Imaging Findings
Other imaging studies that may be helpful in the diagnosis of Zollinger-Ellison syndrome include:
- Endoscopic ultrasound[1]
- Somatostatin receptor scintigraphy (SRS) (octreotide scan)[2]
Gallery
-
A -
B -
C -
D
- Figures A-D: A 37-year-old male with MEN 1. The patient was injected with 6.4 mCi In-111 octreotide, and images were acquired in the anterior and posterior projections at 4 hours (A) and 24 hours (B). SPECT images were also obtained at 24 hours (C, axial, and D, coronal). Findings are consistent with metastatic somatostatin-receptor-positive malignancy involving the lymph nodes either in the peripancreatic or porta hepatis region.[3]
References
- ↑ 1.0 1.1 Tang, Shou-jiang; Wu, Ruonan; Bhaijee, Feriyl (2014). "Zollinger–Ellison Syndrome". Video Journal and Encyclopedia of GI Endoscopy. 1 (3–4): 666–668. doi:10.1016/j.vjgien.2013.06.005. ISSN 2212-0971.
- ↑ Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Ruszniewski P, Le Guludec D; et al. (1997). "Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE)". Gut. 41 (1): 107–14. PMC 1027237. PMID 9274481.
- ↑ Wosnitzer, Brian, and Ramesh Gadiraju. 'The Role Of Nuclear Imaging In Multiple Endocrine Neoplasia I (MEN1)'. Radiol. Case Rep. 5.4 (2010): n. pag. Web.